↓ Skip to main content

Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome

Overview of attention for article published in Cochrane database of systematic reviews, April 2001
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome
Published in
Cochrane database of systematic reviews, April 2001
DOI 10.1002/14651858.cd000144
Pubmed ID
Authors

Soll, Roger, Blanco, Fermin, Soll, R F, Roger Soll, Fermin Blanco

Abstract

This section is under preparation and will be included in the next issue. To compare the effect of synthetic surfactant to natural surfactant in premature infants with established respiratory distress syndrome. Searches were made of the Oxford Database of Perinatal Trials, Medline (MeSH terms: pulmonary surfactant; limits: age groups, newborn infant; publication type, clinical trial), previous reviews including cross references, abstracts, conference and symposia proceedings, expert informants, and journal hand searching in the English language. Randomized controlled trials comparing administration of synthetic surfactants to administration of natural surfactant extracts in premature infants with respiratory distress syndrome were considered for this review. Data regarding clinical outcomes including pneumothorax, patent ductus arteriosus, necrotizing enterocolitis, intraventricular hemorrhage (all intraventricular hemorrhage and severe intraventricular hemorrhage), chronic lung disease, retinopathy of prematurity, and mortality were excerpted by the primary reviewer (R. Soll). Data analysis was conducted according to the standards of the Neonatal Cochrane Review Group. The meta-analysis supports a significant reduction in the risk of pneumothorax (typical relative risk 0.68, 95% CI 0.56, 0.83; typical risk difference -0.04 95% CI -0.06, -0.02). No disadvantages to natural surfactant extract treatment are noted regarding other outcomes. A trend towards reduced mortality is noted in association with natural surfactant extract treatment. Both natural surfactant extracts and synthetic surfactant extracts are effective in the treatment of established respiratory distress syndrome. Comparative trials demonstrate greater early improvement in the requirement for ventilatory support and fewer pneumothoraces associated with natural surfactant extract treatment. On clinical grounds, natural surfactant extracts would seem to be the more desirable choice.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Peru 1 1%
Canada 1 1%
Unknown 95 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 14%
Researcher 12 12%
Student > Master 12 12%
Student > Postgraduate 10 10%
Student > Doctoral Student 10 10%
Other 24 24%
Unknown 16 16%
Readers by discipline Count As %
Medicine and Dentistry 47 48%
Agricultural and Biological Sciences 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Nursing and Health Professions 2 2%
Chemistry 2 2%
Other 16 16%
Unknown 22 22%